NCT04485949 2026-02-10
A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma
Imvax
Phase 2 Active not recruiting
Clinical Trials
7 trialsNCT07091864 2025-11-10
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Mayo Clinic
Phase NA Recruiting
NCT03395587 2024-12-02
GlioVax
Heinrich-Heine University, Duesseldorf
Phase 2 Active not recruiting
NCT03548571 2024-04-03
DEN-STEM
Oslo University Hospital
Phase 2/3 Recruiting
NCT05054400 2023-09-01
Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT05399524 2022-06-01
FUTURE-GB
University of Oxford
Phase NA Unknown
NCT03393000 2021-07-22
INTACT
Diffusion Pharmaceuticals Inc
Phase 3 Terminated